JP7291711B2 - Trpc6阻害剤 - Google Patents

Trpc6阻害剤 Download PDF

Info

Publication number
JP7291711B2
JP7291711B2 JP2020543611A JP2020543611A JP7291711B2 JP 7291711 B2 JP7291711 B2 JP 7291711B2 JP 2020543611 A JP2020543611 A JP 2020543611A JP 2020543611 A JP2020543611 A JP 2020543611A JP 7291711 B2 JP7291711 B2 JP 7291711B2
Authority
JP
Japan
Prior art keywords
mmol
pharmaceutically acceptable
group
compound
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020543611A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021513984A (ja
JPWO2019158572A5 (https=
JP2021513984A5 (https=
Inventor
スティーブン・ブルネット
ツイ・ジャンウェン
マイケル・ディ・ロウ
クリストファー・ロナルド・サーコ
シモン・シュープレナン
マイケル・ロバート・ターナー
シンユエン・ウー
ラナ・ルイーズ・スミス・キーナン
ティエリー・ブイスー
ポール・ニックリン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hydra Biosciences LLC
Original Assignee
Hydra Biosciences LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hydra Biosciences LLC filed Critical Hydra Biosciences LLC
Publication of JP2021513984A publication Critical patent/JP2021513984A/ja
Publication of JPWO2019158572A5 publication Critical patent/JPWO2019158572A5/ja
Publication of JP2021513984A5 publication Critical patent/JP2021513984A5/ja
Application granted granted Critical
Publication of JP7291711B2 publication Critical patent/JP7291711B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
JP2020543611A 2018-02-15 2019-02-13 Trpc6阻害剤 Active JP7291711B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862630907P 2018-02-15 2018-02-15
US62/630,907 2018-02-15
PCT/EP2019/053525 WO2019158572A1 (en) 2018-02-15 2019-02-13 Inhibitors of trpc6

Publications (4)

Publication Number Publication Date
JP2021513984A JP2021513984A (ja) 2021-06-03
JPWO2019158572A5 JPWO2019158572A5 (https=) 2022-02-22
JP2021513984A5 JP2021513984A5 (https=) 2022-02-22
JP7291711B2 true JP7291711B2 (ja) 2023-06-15

Family

ID=65496750

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020543611A Active JP7291711B2 (ja) 2018-02-15 2019-02-13 Trpc6阻害剤

Country Status (5)

Country Link
US (1) US11485740B2 (https=)
EP (1) EP3752499B1 (https=)
JP (1) JP7291711B2 (https=)
CN (1) CN111770918B (https=)
WO (1) WO2019158572A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10202011632RA (en) * 2017-10-27 2021-01-28 Boehringer Ingelheim Int Pyridine carbonyl derivatives and therapeutic uses thereof as trpc6 inhibitors
WO2019241131A1 (en) 2018-06-11 2019-12-19 Pipeline Therapeutics, Inc. Muscarinic acetylcholine m1 receptor antagonists
US12054487B2 (en) 2018-09-04 2024-08-06 Contineum Therapeutics, Inc. Muscarinic acetylcholine M1 receptor antagonists
IL326597A (en) * 2019-10-07 2026-04-01 Contineum Therapeutics Inc Muscarinic M1 acetylcholine receptor antagonists
US11752149B2 (en) 2019-12-02 2023-09-12 Pipeline Therapeutics, Inc. Muscarinic acetylcholine M1 receptor antagonists
AR121846A1 (es) 2020-04-16 2022-07-13 Teijin Pharma Ltd Derivado de arilo o heteroarilo
JP7502462B2 (ja) * 2020-04-16 2024-06-18 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 呼吸器状態を処置するためのtrpc6阻害剤
US20250042873A1 (en) * 2021-08-24 2025-02-06 The Johns Hopkins University Compositions and methods for treating proteotoxicity-associated diseases
CN121729232A (zh) * 2023-08-18 2026-03-24 勃林格殷格翰国际有限公司 用于治疗局灶节段性肾小球硬化症的trpc6抑制剂

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012037349A2 (en) 2010-09-17 2012-03-22 Glaxosmithkline Llc Compounds
JP2013536873A (ja) 2010-09-06 2013-09-26 グアンジョウ インスティテュート オブ バイオメディスン アンド ヘルス,チャイニーズ アカデミー オブ サイエンスィズ アミド化合物
CN103694242A (zh) 2013-12-10 2014-04-02 中国科学院昆明植物研究所 吡唑并嘧啶类化合物及其药物组合物和其在制药中的应用
JP2014528921A (ja) 2011-08-10 2014-10-30 ウニベルジテート・ライプツィヒ Trpc6関連疾患の治療に使用するための二環式ラブダンジテルペン
WO2014192865A1 (ja) 2013-05-30 2014-12-04 大日本住友製薬株式会社 フェニルピペラジン誘導体

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040010713A (ko) * 2001-06-15 2004-01-31 야마노우치세이야쿠 가부시키가이샤 페닐피리딘 카보닐 피페라진 유도체
US7759348B2 (en) * 2003-07-30 2010-07-20 Xenon Pharmaceuticals Inc. Pyridazine derivatives and their use as therapeutic agents
CN102970965A (zh) 2010-04-05 2013-03-13 Sk化学公司 含有pde5抑制剂的减少皮肤皱纹的合成物
CN107253952B (zh) * 2017-08-01 2019-07-30 烟台大学 具有抗胃癌活性的trpc6抑制剂及其制备方法和用途
SG10202011632RA (en) * 2017-10-27 2021-01-28 Boehringer Ingelheim Int Pyridine carbonyl derivatives and therapeutic uses thereof as trpc6 inhibitors
CN111868055B (zh) * 2018-02-16 2024-03-08 勃林格殷格翰国际有限公司 Trpc6的抑制剂
JP7585227B2 (ja) * 2019-04-12 2024-11-18 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Trpc6阻害剤
JP7502462B2 (ja) * 2020-04-16 2024-06-18 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 呼吸器状態を処置するためのtrpc6阻害剤

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013536873A (ja) 2010-09-06 2013-09-26 グアンジョウ インスティテュート オブ バイオメディスン アンド ヘルス,チャイニーズ アカデミー オブ サイエンスィズ アミド化合物
WO2012037349A2 (en) 2010-09-17 2012-03-22 Glaxosmithkline Llc Compounds
JP2014528921A (ja) 2011-08-10 2014-10-30 ウニベルジテート・ライプツィヒ Trpc6関連疾患の治療に使用するための二環式ラブダンジテルペン
WO2014192865A1 (ja) 2013-05-30 2014-12-04 大日本住友製薬株式会社 フェニルピペラジン誘導体
CN103694242A (zh) 2013-12-10 2014-04-02 中国科学院昆明植物研究所 吡唑并嘧啶类化合物及其药物组合物和其在制药中的应用

Also Published As

Publication number Publication date
US11485740B2 (en) 2022-11-01
JP2021513984A (ja) 2021-06-03
EP3752499A1 (en) 2020-12-23
WO2019158572A1 (en) 2019-08-22
CN111770918A (zh) 2020-10-13
EP3752499B1 (en) 2024-03-27
US20200399282A1 (en) 2020-12-24
CN111770918B (zh) 2024-02-27

Similar Documents

Publication Publication Date Title
JP7291711B2 (ja) Trpc6阻害剤
JP7217273B2 (ja) ピリジンカルボニル誘導体およびtrpc6阻害剤としてのその治療的使用
JP7301861B2 (ja) Trpc6の阻害剤
JP7585227B2 (ja) Trpc6阻害剤
EP4705296A1 (en) Heteroarylindole inhibitors of apol-1
WO2025231011A1 (en) Heteroarylindole inhibitors of apol-1
HK40035138B (en) Inhibitors of trpc6
HK40035138A (en) Inhibitors of trpc6
BR112020007818B1 (pt) Compostos derivados de piridina carbonila, sal farmaceuticamente aceitável dos mesmos, composição farmacêutica que os compreende e seu uso como inibidores de trpc6

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220210

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220210

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230124

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20230119

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230421

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230523

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230605

R150 Certificate of patent or registration of utility model

Ref document number: 7291711

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313117

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350